| UniProt ID | PNPO_HUMAN | |
|---|---|---|
| UniProt AC | Q9NVS9 | |
| Protein Name | Pyridoxine-5'-phosphate oxidase | |
| Gene Name | PNPO | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 261 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP).. | |
| Protein Sequence | MTCWLRGVTATFGRPAEWPGYLSHLCGRSAAMDLGPMRKSYRGDREAFEETHLTSLDPVKQFAAWFEEAVQCPDIGEANAMCLATCTRDGKPSARMLLLKGFGKDGFRFFTNFESRKGKELDSNPFASLVFYWEPLNRQVRVEGPVKKLPEEEAECYFHSRPKSSQIGAVVSHQSSVIPDREYLRKKNEELEQLYQDQEVPKPKSWGGYVLYPQVMEFWQGQTNRLHDRIVFRRGLPTGDSPLGPMTHRGEEDWLYERLAP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 29 | Phosphorylation | LSHLCGRSAAMDLGP HHHHHCCHHCHHHHH | 12.98 | 20068231 | |
| 40 | Phosphorylation | DLGPMRKSYRGDREA HHHHCCHHHCCCHHH | 15.08 | 17287340 | |
| 41 | Phosphorylation | LGPMRKSYRGDREAF HHHCCHHHCCCHHHH | 22.96 | 20068231 | |
| 51 | Phosphorylation | DREAFEETHLTSLDP CHHHHHHHCCCCCCH | 18.26 | 23186163 | |
| 54 | Phosphorylation | AFEETHLTSLDPVKQ HHHHHCCCCCCHHHH | 21.46 | 28122231 | |
| 55 | Phosphorylation | FEETHLTSLDPVKQF HHHHCCCCCCHHHHH | 36.82 | 28122231 | |
| 157 | Phosphorylation | PEEEAECYFHSRPKS CHHHHHHEEECCCCC | 8.88 | 26356563 | |
| 160 | Phosphorylation | EAECYFHSRPKSSQI HHHHEEECCCCCCCC | 40.14 | 26356563 | |
| 164 | Phosphorylation | YFHSRPKSSQIGAVV EEECCCCCCCCCCCC | 30.11 | 23898821 | |
| 165 | Phosphorylation | FHSRPKSSQIGAVVS EECCCCCCCCCCCCC | 31.76 | 21082442 | |
| 172 | Phosphorylation | SQIGAVVSHQSSVIP CCCCCCCCCCCCCCC | 14.81 | 28857561 | |
| 175 | Phosphorylation | GAVVSHQSSVIPDRE CCCCCCCCCCCCCHH | 22.58 | 28857561 | |
| 176 | Phosphorylation | AVVSHQSSVIPDREY CCCCCCCCCCCCHHH | 19.93 | 28857561 | |
| 181 | Methylation | QSSVIPDREYLRKKN CCCCCCCHHHHHHHH | 29.16 | 115488007 | |
| 183 | Phosphorylation | SVIPDREYLRKKNEE CCCCCHHHHHHHHHH | 16.83 | - | |
| 187 | Ubiquitination | DREYLRKKNEELEQL CHHHHHHHHHHHHHH | 64.26 | - | |
| 212 | Phosphorylation | SWGGYVLYPQVMEFW CCCCEEEHHHHHHHH | 4.99 | - | |
| 238 | Phosphorylation | VFRRGLPTGDSPLGP EEECCCCCCCCCCCC | 59.68 | 30266825 | |
| 241 | Phosphorylation | RGLPTGDSPLGPMTH CCCCCCCCCCCCCCC | 24.30 | 30266825 | |
| 246 | Sulfoxidation | GDSPLGPMTHRGEED CCCCCCCCCCCCCCC | 4.71 | 30846556 | |
| 247 | Phosphorylation | DSPLGPMTHRGEEDW CCCCCCCCCCCCCCC | 16.14 | 29255136 | |
| 256 | Phosphorylation | RGEEDWLYERLAP-- CCCCCCHHHHCCC-- | 8.51 | 27642862 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PNPO_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PNPO_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PNPO_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| FUMH_HUMAN | FH | physical | 26344197 | |
| GMPPB_HUMAN | GMPPB | physical | 26344197 | |
| CH10_HUMAN | HSPE1 | physical | 26344197 | |
| PCP_HUMAN | PRCP | physical | 26344197 | |
| MSS4_HUMAN | RABIF | physical | 26344197 | |
| SGT1_HUMAN | SUGT1 | physical | 26344197 | |
| TALDO_HUMAN | TALDO1 | physical | 26344197 | |
| TRXR1_HUMAN | TXNRD1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 610090 | Pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY. | |